Takahiro Tsujikawa

20PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Other biomedical and clinical sciences not elsewhere classifiedTime-series analysisPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 02, 2026
Clinical Outcomes of Endoscopic Submucosal Dissection and Transoral Videolaryngoscopic Surgery for Superficial Hypopharyngeal Cancers.

|Apr 30, 2026
Correction: Kobayashi et al. Pathogenesis of Graves' Disease Determined Using Single-Cell Sequencing with Thyroid Autoantigen Peptide Stimulation in B Cells. Cells 2025, 14, 1102.

|Jan 18, 2026
Rising Incidence of Tongue Cancer Surgeries Among Middle-Aged and Older Women in Japan: A Nationwide Claims-Based Analysis From 2014 to 2022.

Masamitsu Kido, Takahiro Tsujikawa, Kengo Yoshii

|Aug 14, 2025
Prognostic Implications of T Cell Receptor Repertoire Diversity in Cervical Lymph Nodes of Oral Squamous Cell Carcinoma Patients.

Kenichi Kumagai, Yoshiki Hamada, Akihisa Horie

|Jan 24, 2025
Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.

Aya Miyagawa-Hayashino, Tetsuya Imura, Toshiaki Takezawa

|Dec 17, 2024
The Novel HDAC Inhibitor OBP-801 Promotes MHC Class I Presentation Through LMP2 Upregulation, Enhancing the PD-1-Targeting Therapy in Clear Cell Renal Cell Carcinoma.

Tsukasa Narukawa, Shusuke Yasuda, Mano Horinaka

Pageof 4

Frequent Collaborators

4 joint publications

Shigeru Hirano

3 joint publications

James M Reuben

2 joint publications

Vancheswaran Gopalakrishnan

2 joint publications

Courtney W Hudgens